Adjuvant treatment and molecular mechanism of probiotic compounds in patients with gastric cancer after gastrectomy-Reference-Cited by-同舟云学术

Adjuvant treatment and molecular mechanism of probiotic compounds in patients with gastric cancer after gastrectomy

Published:2021 Issue: Volume: Page:
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Zheng Cihua¹²³⁴,Chen Tingtao¹²³⁴⁵,Lu Jiachen⁵⁶⁷⁸⁴,Wei Kehong⁵⁶⁷⁸⁴,Tian Huakai¹²³⁴,Liu Weidong¹²³⁴,Xu Tian¹²³⁴,Wang Xinyu¹²³⁴,Wang Shuai¹²³⁴,Yang Rong¹²³⁴,Yang Yulu¹²³⁴,Liu Zhaoxia⁹²³⁴,Wei Hong¹⁰¹¹¹²¹³⁴,Deng Xiaorong¹²³⁴

Affiliation:

1. Department of Gastrointestinal Surgery

2. The Second Affiliated Hospital of Nanchang University

3. Nanchang

4. P.R. China

5. National Engineering Research Center for Bioengineering Drugs and the Technologies

6. Institute of Translational Medicine

7. Nanchang University

8. Nanchang 330031

9. Department of Obstetrics and Gynecology

10. Precision Medicine Institute

11. The First Affiliated Hospital

12. Sun Yat-sen University

13. Guangzhou

Abstract

In the present study, probiotic compounds were studied through clinical and animal model verification to try to find auxiliary treatment measures after gastrectomy, and explore their potential mechanism.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangxi Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2021/FO/D1FO01375K

Reference51 articles.

1. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries